Medtronic - Pulse Oximeter - Nellcor PM100N Bedside
- Lead Time - 14 - 18 weeks
- Warranty - 2 years
- Note on price - Price quoted EXW
- Payment - 40% Advance Payment / 60% payment on shipping. Payments to be made by Bank Direct Payment.
- CIP – if the product is supplier from abroad
- EXW – if product is supplied within the Borrower’s country
On return of the ROI, Medtronic will obtain actual shipping costs per product based on quantity and destination as per the applicable Incoterm. Actual shipping costs will be in addition to the quoted prices below and will be detailed in the contract.
Medtronic products have recognized regulatory approvals/certificates. Medtronic will provide the Borrower with a copy of these or other documentary evidence of the approval/certification, prior to shipment. An independent pre-shipping inspection at the place of leaving will be undertaken. This can be arranged by Medtronic and the costs passed-through to the Borrower, or by the Borrower.
Support and maintenance are most often part of the warranty on the device.
Printed user and service manuals will be provided with each piece of equipment. In addition, all product manuals can be obtained at: https://www.medtronic.com/covidien/en-us/support/product-manuals.html
Clinical training is part of the Medtronic responsibility and will be provided. Medtronic has online training resources on its website. Depending on specific needs, Medtronic education team can arrange tailored videoconferences with users. Medtronic recommends that these only be arranged, after the online training has been completed.
Medtronic (www.medtronic.com) is one of the largest medical device companies in the world with operations in 150 countries, and products to treat 70 health conditions that include cardiac devices, cranial and spine robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Medtronic’s BFP Offer relates only to devices to treat COVID-19. Medtronic has its operational headquarters in Minneapolis, Minnesota, USA and legal headquarters in Dublin, Eire.
Pulse oximeters are used to noninvasively measure saturated hemoglobin in tissue capillaries. These devices are comprised of the pulse oximeter and a sensor/probe that may designed to adhere to the patient’s finger (most common option), toe, forehead, or ear. The probe contains light emitting diodes (LEDs) that emit red and infrared lights that pass through the arteries and feeds information back to a microprocessor.
Pulse oximeters measure oxygenated and deoxygenated hemoglobin using these lights to read changing absorbance in hemoglobin due to pulsating blood flow in the arteries. This process allows for monitoring of oxygenated hemoglobin versus deoxygenated hemoglobin (not measured through light), which is revealed as an oxygenation percentage (i.e., 70% to 100%). Through this process, pulse oximeters allow for accurate monitoring of pulse rate and oxygenation percentage while providing a means of rapid detection of hypoxia, or decreased saturated oxygen rates, before onset of pathological injury and clinical symptoms.
Additionally, this information helps clinicians assess the amount of oxygen being carried in the blood and evaluate the need for supplemental oxygen.
Pulse Oximeter sensors
ECRI recommends using a higher ratio of adhesive sensors to minimize the burden and risk from cleaning and disinfecting reusable sensors between COVID-19 patient uses.
When estimating adhesive sensor quantities, ECRI recommends planning for five adhesive sensors per week per device, which is an increase from a normal condition estimates of four sensors per week. Adhesive sensors are intended for single patient use only.
For reusable sensors, ECRI recommends purchasing 12 sensors per device.